|
|
||||||||
1 Institut National de la Santé et de la Recherche Médicale Unité-449 and Centre de Recherche en Nutrition Humaine de Lyon, Faculté de Médecine R.T.H. Laënnec, F-69372 Lyon; 3 Institut de Génétique et Biologie Moléculaire et Cellulaire, 67404 Illkirch, France; and 2 Department of Medicine, Division of Geriatrics, Helsinki University Central Hospital, 00290 Helsinki, Finland
Fatty acid transporter protein
(FATP)-1 mRNA expression was investigated in skeletal muscle and in
subcutaneous abdominal adipose tissue of 17 healthy lean, 13 nondiabetic obese, and 16 obese type 2 diabetic subjects. In muscle,
FATP-1 mRNA levels were higher in lean women than in lean men (2.2 ± 0.1 vs. 0.6 ± 0.2 amol/µg total RNA, P < 0.01). FATP-1 mRNA expression was decreased in skeletal muscle in obese
women both in nondiabetic and in type 2 diabetic patients
(P < 0.02 vs. lean women in both groups), and in all
women there was a negative correlation with basal FATP-1 mRNA level and
body mass index (r =
0.74, P < 0.02). In men, FATP-1 mRNA was expressed at similar levels in the three groups both in skeletal muscle (0.6 ± 0.2, 0.6 ± 0.2, and
0.8 ± 0.2 amol/µg total RNA in lean, obese, and type 2 diabetic
male subjects) and in adipose tissue (0.9 ± 0.2 amol/µg total
RNA in the 3 groups). Insulin infusion (3 h) reduced FATP-1 mRNA levels in muscle in lean women but not in lean men. Insulin did not affect FATP-1 mRNA expression in skeletal muscle in obese nondiabetic or in
type 2 diabetic subjects nor in subcutaneous adipose tissue in any of
the three groups. These data show a gender-related difference in the
expression of the fatty acid transporter FATP-1 in skeletal muscle of
lean individuals and suggest that changes in FATP-1 expression may not
contribute to a large extent to the alterations in fatty acid uptake in
obesity and/or type 2 diabetes.
fatty acids; insulin; insulin resistance; obesity; type 2 diabetes mellitus; hyperinsulinemic clamp; reverse transcription-polymerase chain reaction; messenger ribonucleic acid
This article has been cited by other articles:
![]() |
S. Y. Park, H. K. Shin, J. H. Lee, C. D. Kim, W. S. Lee, B. Y. Rhim, and K. W. Hong Cilostazol Ameliorates Metabolic Abnormalities with Suppression of Proinflammatory Markers in a db/db Mouse Model of Type 2 Diabetes via Activation of Peroxisome Proliferator-Activated Receptor {gamma} Transcription J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 571 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bonen, A. Chabowski, J. J. F. P Luiken, and J. F. C. Glatz Mechanisms and Regulation of Protein-Mediated Cellular Fatty Acid Uptake: Molecular, Biochemical, and Physiological Evidence Physiology, February 1, 2007; 22(1): 15 - 28. [Full Text] [PDF] |
||||
![]() |
H. Doege and A. Stahl Protein-mediated Fatty Acid uptake: novel insights from in vivo models. Physiology, August 1, 2006; 21: 259 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wu, A. M. Ortegon, B. Tsang, H. Doege, K. R. Feingold, and A. Stahl FATP1 Is an Insulin-Sensitive Fatty Acid Transporter Involved in Diet-Induced Obesity. Mol. Cell. Biol., May 1, 2006; 26(9): 3455 - 3467. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bach, D. Naon, S. Pich, F. X. Soriano, N. Vega, J. Rieusset, M. Laville, C. Guillet, Y. Boirie, H. Wallberg-Henriksson, et al. Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle: Effects of Type 2 Diabetes, Obesity, Weight Loss, and the Regulatory Role of Tumor Necrosis Factor {alpha} and Interleukin-6 Diabetes, September 1, 2005; 54(9): 2685 - 2693. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Wilmsen, T. P. Ciaraldi, L. Carter, N. Reehman, S. R. Mudaliar, and R. R. Henry Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E354 - E362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Morris, H.-J. Lee, and L. M. Predko Gender Differences in the Membrane Transport of Endogenous and Exogenous Compounds Pharmacol. Rev., June 1, 2003; 55(2): 229 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Perseghin, P. Scifo, M. Danna, A. Battezzati, S. Benedini, E. Meneghini, A. Del Maschio, and L. Luzi Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E556 - E564. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zou, C. C. DiRusso, V. Ctrnacta, and P. N. Black Fatty Acid Transport in Saccharomyces cerevisiae. DIRECTED MUTAGENESIS OF FAT1 DISTINGUISHES THE BIOCHEMICAL ACTIVITIES ASSOCIATED WITH Fat1p J. Biol. Chem., August 16, 2002; 277(34): 31062 - 31071. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |